Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 15:59
Elite Pharmaceuticals Price: 0.6168 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 0.6668 | 0.6668 | 0.6001 | 0.6177 | 3.129M |
| Nov 20, 2024 | 0.685 | 0.70 | 0.627 | 0.6635 | 1.534M |
| Nov 19, 2024 | 0.6999 | 0.70 | 0.6551 | 0.675 | 2.586M |
| Nov 18, 2024 | 0.6107 | 0.72 | 0.6106 | 0.6652 | 7.840M |
| Nov 15, 2024 | 0.4999 | 0.59 | 0.481 | 0.5615 | 5.069M |
| Nov 14, 2024 | 0.58 | 0.585 | 0.48 | 0.5177 | 3.546M |
| Nov 13, 2024 | 0.57 | 0.589 | 0.56 | 0.5751 | 2.083M |
| Nov 12, 2024 | 0.5389 | 0.57 | 0.53 | 0.5601 | 1.450M |
| Nov 11, 2024 | 0.515 | 0.55 | 0.515 | 0.541 | 1.892M |
| Nov 08, 2024 | 0.5099 | 0.515 | 0.495 | 0.5098 | 1.151M |
| Nov 07, 2024 | 0.5099 | 0.51 | 0.481 | 0.4999 | 1.428M |
| Nov 06, 2024 | 0.524 | 0.533 | 0.48 | 0.515 | 1.553M |
| Nov 05, 2024 | 0.52 | 0.52 | 0.49 | 0.5098 | 781288.0 |
| Nov 04, 2024 | 0.51 | 0.5299 | 0.5001 | 0.5101 | 1.454M |
| Nov 01, 2024 | 0.4507 | 0.5112 | 0.45 | 0.5014 | 1.948M |
| Oct 31, 2024 | 0.45 | 0.4699 | 0.435 | 0.443 | 1.936M |
| Oct 30, 2024 | 0.51 | 0.5150 | 0.4321 | 0.435 | 6.122M |
| Oct 29, 2024 | 0.575 | 0.5799 | 0.502 | 0.51 | 4.531M |
| Oct 28, 2024 | 0.55 | 0.5768 | 0.5474 | 0.569 | 1.667M |
| Oct 25, 2024 | 0.58 | 0.615 | 0.5076 | 0.5401 | 4.115M |
| Oct 24, 2024 | 0.49 | 0.585 | 0.4801 | 0.5755 | 4.253M |
| Oct 23, 2024 | 0.6076 | 0.6699 | 0.4469 | 0.4702 | 12.94M |
| Oct 22, 2024 | 0.7396 | 0.7549 | 0.43 | 0.60 | 21.04M |
| Oct 21, 2024 | 0.6177 | 0.705 | 0.6125 | 0.705 | 11.47M |
| Oct 18, 2024 | 0.50 | 0.589 | 0.5000 | 0.585 | 7.765M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.0285
Minimum
Dec 29 2022
0.705
Maximum
Oct 21 2024
0.0915
Average
0.0578
Median
Jan 29 2021
Price Benchmarks
| Biomarin Pharmaceutical Inc | 64.25 |
| BioCardia Inc | 2.27 |
| Zevra Therapeutics Inc | 9.63 |
| Verrica Pharmaceuticals Inc | 1.00 |
| Terns Pharmaceuticals Inc | 5.79 |
Price Related Metrics
| PS Ratio | 9.107 |
| Price to Book Value | 13.94 |
| Price to Free Cash Flow | 384.69 |
| Earnings Yield | -1.42% |
| Market Cap | 658.91M |
| Operating PE Ratio | 44.36 |
| Normalized PE Ratio | 170.76 |